🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#BREAKING The FDA has approved cabozantinib for patients with advanced neuroendocrine tumors (NETs) based on evidence from the #CABINET trial, led by Jennifer Chan, MD, MPH of Dana-Farber. Release ▶️ bit.ly/42433MO

Fantastic time hosting NANETs Regional Symposium University of Arizona Cancer Center. Great talks, great company, and just the right amount of desert sun. Grateful for the collaboration and looking forward to the next one! #NANETs Rachna Shroff, MD, MS, FASCO Aman Chauhan Pamela Kunz, MD, FASCO University of Arizona COM - Division of Heme/Onc Bital Savir-Baruch MD, FACNM

Calling all healthcare providers! Your insights are crucial in transforming NET patient care. Complete the NETPact provider survey to help guide future educational resources and advocacy initiatives. 🔗 loom.ly/0LZed14 #ProviderSurvey #NETCare #NETPact #NANETS

Help shape the future of NET care! Take a few minutes to complete the NETPact patient survey and share your experiences. Your input is vital in driving advocacy efforts and improving support for the NET community. 🔗 loom.ly/0LZed14 #PatientSurvey #NETPact #NANETS

I’m honored to be named an Advocacy Champion at the ASCO #ASCOAdvocacySummit! Over the past year, I connected with lawmakers & sent personalized messages to Congress—advocating for better cancer care & research. Proud to be in DC today continuing this work with ASCO!

NANETS is now accepting collaboration submissions! If you're working on a neuroendocrine tumor (NET) research project and seeking partners, funding, or resources, we want to hear from you. Fill out the form here: loom.ly/hmu3CMg #MedicalCollaboration #NANETS

NANETS joined the SIO Meets NANETS session at the SIO Annual Meeting, reinforcing our commitment to multidisciplinary NET care. Dr. Michael C. Soulen's inspiring lecture on interventional oncology role in NET treatment was a highlight! #NETCare #SIO #MedicalCollaboration #NANETS

The Senate recently confirmed Jayanta Bhattacharya, M.D., PhD, as Director of the National Institutes of Health (NIH) in a 53-47 vote. Dr. Bhattacharya is prepared to lead the NIH and address key public health challenges. loom.ly/hKQQPl0

Not long to go until this month's NETChatter on Thursday 24th April at 6pm UK / 1pm EST. DM us for the link to join. All welcome. iacovos michael 🇨🇦 NANETS Pheo Para Alliance CarcinoidCancer CCF Neuroendocrine Cancer Foundation NET Research Foundation NCAN NET Cancer Day #Collaboration #patients1st #ZebraStrong

Join us in Los Angeles for the NET Regional Conference, May 17! This program offers essential education on NET pathology, diagnosis, and treatment strategies. Let’s advance NET care and improve patient outcomes! 🔗 loom.ly/nUiw-5Q #NETCare #MedicalEducation #NANETS

NANETS is heading to Austin, TX in October 2025 for our Annual NET Medical Symposium! Explore the vibrant city, from BBQ to live music and outdoor adventures. Don’t miss this premier event for NET education & networking. Registration opens this spring! #NETConference #NANETS

Congrats to Dr. Heloisa Soares, named an ASCO Advocacy Champion! As a Speaker’s Circle honoree, she’s a powerful voice for cancer patients, providers & researchers — driving policy change for better care. We're proud to celebrate her impact! 👏 #ASCO #AdvocacyChampion #NANETS

Join us in Los Angeles for the NET Regional Conference, May 17! This program offers essential education on NET pathology, diagnosis, and treatment strategies. Let’s advance NET care and improve patient outcomes! 🔗 loom.ly/nUiw-5Q #NETCare #MedicalEducation #NANETS

Take action in just a few clicks! The ACT Network makes it easy to support ASCO’s cancer care priorities. Send pre-drafted letters to lawmakers, track key legislation, and stay informed. 👉 Anyone can register: loom.ly/4HzdEBo #Advocacy #NANETS #ACTNetwork #ASCO

At NANETS, our mission is to enhance outcomes for patients with Neuroendocrine Tumors (NETs) through: 🔬 Multidisciplinary medical education 💡 NET-focused research 📚 Development of clinical guidelines 🤝 Fostering knowledge exchange and innovation loom.ly/G8kYEiw

Got a great idea for a project, research, or event? Submit your proposal through our form and explore opportunities to partner with us in advancing NET care, education, and research. 📝 Let’s collaborate: loom.ly/hmu3CMg #NETs #MedicalCollaboration #NANETS

New research explores how long non-coding RNA MEG3 may suppress tumor growth in thyroid cancer by targeting the miR-182–FOXO1 axis. These findings highlight a potential therapeutic pathway for managing thyroid malignancies. 🧬 🔗 Read more: loom.ly/eaPHLcQ #NANETS

Big news! 📣 LACNETS is now the Neuroendocrine Cancer Foundation (NCF)! This new name reflects our growing mission to serve the Neuroendocrine Cancer community with greater clarity, connection, and care. 💛 🌐 Visit us at our new home: loom.ly/JwXpBBY

Calling all healthcare providers! Your insights are crucial in transforming NET patient care. Complete the NETPact provider survey to help guide future educational resources and advocacy initiatives. 🔗 loom.ly/0LZed14 #ProviderSurvey #NETCare #NETPact #NANETS

Nominations are open for the 2025 NANETS Awards! 🏆 Help us recognize excellence in NET research, clinical practice, mentorship, and diversity initiatives. Learn more & nominate: nanets.net/about/nanets-a… #NANETSAwards